Cargando…
Targeting PI3K Pathway in Pancreatic Ductal Adenocarcinoma: Rationale and Progress
SIMPLE SUMMARY: Pancreatic cancer has a dismal 5-year survival rate of 10%, making it one of the deadliest forms of malignancy. The poor prognosis associated with this disease is because it is resistant to almost every type of chemotherapy. Another major hallmark of pancreatic cancer is the presence...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430624/ https://www.ncbi.nlm.nih.gov/pubmed/34503244 http://dx.doi.org/10.3390/cancers13174434 |